Cytosorbents Corp Amortization
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-03-30
- Cytosorbents Corp amortization for the quarter ending 2025-12-31 was $100.00K.
- Cytosorbents Corp amortization for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- Cytosorbents Corp amortization for the quarter ending 2025-06-30 was $37.20K, a 17.15% decline year-over-year.
- Cytosorbents Corp amortization for the quarter ending 2025-03-31 was $62.80K, a 13.97% increase year-over-year.
- Cytosorbents Corp amortization for fiscal 2025 was $300.00K, a 50.00% increase from fiscal 2024.
- Cytosorbents Corp amortization for fiscal 2024 was $200.00K, a 10.25% decline from fiscal 2023.
- Cytosorbents Corp amortization for fiscal 2023 was $222.84K, a 0.00% change from fiscal 2022.
- Cytosorbents Corp amortization for fiscal 2022 was $222.84K, a 38.91% increase from fiscal 2021.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 12 month as first filed | Amortization 191 month | Amortization 203 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $200.00K derived: sum of 2 quarters · filed 2026-03-30 | $237.20K derived: sum of 3 quarters · filed 2026-03-30 | $300.00K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $137.20K derived: sum of 2 quarters · filed 2025-11-13 | $200.00K 10-Q · filed 2025-11-13 | $200.00K derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2025-06-30 | $37.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $100.00K 10-Q · filed 2025-08-07 | $100.00K derived: sum of 3 quarters · filed 2026-03-30 | $200.00K derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2025-03-31 | $62.80K 10-Q · filed 2025-05-14 | $62.80K derived: sum of 2 quarters · filed 2026-03-30 | $162.80K derived: sum of 3 quarters · filed 2026-03-30 | $207.70K derived: sum of 4 quarters · filed 2026-03-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $100.00K derived: sum of 2 quarters · filed 2026-03-30 | $144.90K derived: sum of 3 quarters · filed 2026-03-30 | $200.00K 10-K · filed 2026-03-30 | $235.15K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-13 | $144.90K derived: sum of 2 quarters · filed 2025-11-13 | $200.00K 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | $44.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $100.00K 10-Q · filed 2025-08-07 | |||||
| 2024-03-31 | $55.10K 10-Q · filed 2025-05-14 | ||||||
| 2023-12-31 | $222.84K 10-K · filed 2024-03-15 | ||||||
| 2022-12-31 | $222.84K 10-K · filed 2025-03-31 | $194.06K 10-K · filed 2023-03-09 | |||||
| 2021-12-31 | $160.42K 10-K · filed 2024-03-15 | ||||||
| 2020-12-31 | $106.84K 10-K · filed 2023-03-09 | ||||||
| 2019-12-31 | $85.80K 10-K · filed 2022-03-10 | ||||||
| 2018-12-31 | $61.08K 10-K · filed 2021-03-09 | ||||||
| 2017-12-31 | $40.49K 10-K · filed 2020-03-05 | ||||||
| 2016-12-31 | $35.50K 10-K · filed 2019-03-07 | ||||||
| 2015-12-31 | $25.57K 10-K · filed 2018-03-08 | ||||||
| 2014-12-31 | $17.12K 10-K · filed 2017-03-03 | ||||||
| 2013-12-31 | $24.46K 10-K · filed 2015-03-31 | $132.15K 10-K · filed 2014-03-31 | |||||
| 2012-12-31 | $25.29K 10-K · filed 2014-03-31 | $107.69K 10-K · filed 2013-04-03 | |||||
| 2011-12-31 | $15.40K 10-K · filed 2013-04-03 |